当前位置: 首页 > 期刊 > 《中国实用医药》 > 2018年第12期
编号:13229643
阿司匹林抵抗与冠心病合并2型糖尿病患者MACE的临床关系(1)
http://www.100md.com 2018年4月25日 《中国实用医药》 2018年第12期
     【摘要】 目的 探讨阿司匹林抵抗(AR)与冠心病合并2型糖尿病患者不良心血管事件(MACE)发生的关系。方法 120例冠心病合并2型糖尿病患者, 根据是否发生AR分为AR组与非AR组, 比较两组的MACE发生情况, 并根据患者是否发生MACE分为发生组与未发生组, 比较患者的一般资料, 进而分析AR等与冠心病合并2型糖尿病患者发生MACE的关系。结果 AR组MACE发生率51.43%明显高于非AR组的23.53%, 差异具有统计学意义(P<0.05)。发生组性别、收缩压、舒张压、总胆固醇(TC)、高密度脂蛋白胆固醇(HDL-C)、空腹血糖(FBG)水平与未发生组比较差异无统计学意义(P>0.05);发生组年龄、体质量指数(BMI)、三酰甘油(TG)、低密度脂蛋白胆固醇(LDL-C)、糖化血红蛋白(HbA1c)、AR发生情况与未发生组比较差异具有统计学意义(P<0.05)。经Logistic分析分析, 年龄、LDL-C、HbA1c、AR是影响MACE发生的因素(P<0.05)。结论 存在AR的冠心病合并糖尿病患者发生MACE的风险更高, 年龄、LDL-C、HbA1c、AR均是导致MACE发生的危险因素。

    【关键词】 阿司匹林抵抗;2型糖尿病;不良心血管事件;冠心病

    DOI:10.14163/j.cnki.11-5547/r.2018.12.002

    【Abstract】 Objective To investigate the relationship between aspirin resistance (AR) and main adverse cardiovascular events (MACE) in patients with type 2 diabetes mellitus complicated with coronary heart disease. Methods A total of 120 patients with type 2 diabetes mellitus complicated with coronary heart disease were divided by occurrence of AR into AR group and non-AR group. The occurrence of MACE in the two groups was compared, and the patients were divided by occurrence of MACE into the occurrence group and non-occurrence group. The general data of patients was compared, and then the relationship between AR and MACE in patients with coronary heart disease and type 2 diabetes mellitus was analyzed. Results AR group had obviously higher incidence of MACE as 51.43% than 23.53% in non-AR group, and the difference was statistically significant (P<0.05). The occurrence group had no statistically significant difference in gender, systolic blood pressure, diastolic blood pressure, total cholesterol (TC), high density lipoprotein cholesterol (HDL-C), and fasting blood glucose (FBG) level, comparing with non-occurrence group (P>0.05). The occurrence group had statistically significant difference in age, body mass index (BMI), triglyceride (TG), low density lipoprotein cholesterol (LDL-C), glycosylated hemoglobin (HbA1c) and AR occurrence, comparing with non-occurrence group (P<0.05). According to Logistic analysis, age, LDL-C, HbA1c and AR were factors affecting the occurrence of MACE (P<0.05). Conclusion There is a higher risk of MACE in patients with coronary heart disease and diabetes mellitus who have AR. Age, LDL-C, HbA1c and AR are all risk factors for the occurrence of MACE.

    【Key words】 Aspirin resistance; Type 2 diabetes mellitus; Main adverse cardiovascular events; Coronary heart disease

    多數冠心病患者合并有2型糖尿病, 二者常互为因果, 加重患者的病情, 增加MACE的发生风险[1, 2]。抗血小板治疗是预防心血管疾病和血栓事件发生的重要手段, 受到个体差异影响, 不同个体对抗血小板药物治疗的反应存在差异, 在接受抗血小板药物治疗仍会发生血栓事件, 即“血小板抵, http://www.100md.com(梁华桂)
1 2下一页